Perturbation of microRNAs in rat heart during chronic doxorubicin treatment

PLoS ONE

Volumn 7, Issue 7, 2012, Pages

  Vacchi Suzzi, Caterina ^a   Bauer, Yasmina ^b   Berridge, Brian R ^c   Bongiovanni, Sandrine ^a   Gerrish, Kevin ^d   Hamadeh, Hisham K ^e   Letzkus, Martin ^a   Lyon, Jonathan ^f   Moggs, Jonathan ^a   Paules, Richard S ^d   Pognan, François ^a   Staedtler, Frank ^a   Vidgeon Hart, Martin P ^f   Grenet, Olivier ^a   Couttet, Philippe ^a  

^a NOVARTIS PHARMA AG   (Switzerland)

^b ACTELION PHARMACEUTICALS LTD   (Switzerland)

^c GLAXOSMITHKLINE   (United States)

^d NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES   (United States)

^e AMGEN INC   (United States)

^f GLAXOSMITHKLINE   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

DOXORUBICIN; ETOPOFOS; MESSENGER RNA; MICRORNA; RAZOXANE;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CARDIOTOXICITY; COMPUTER MODEL; CONTROLLED STUDY; DOSE RESPONSE; DRUG EFFECT; DRUG MEGADOSE; EMBRYO; GENE; GENE TARGETING; HISTOPATHOLOGY; HUMAN; HUMAN CELL; LONG TERM CARE; MALE; NONHUMAN; PREDICTION; RAT; SIPA1 GENE; UPREGULATION;

ADAPTOR PROTEINS, SIGNAL TRANSDUCING; ANIMALS; ANTIBIOTICS, ANTINEOPLASTIC; BIOLOGICAL MARKERS; CARDIOMYOPATHIES; DOXORUBICIN; GTPASE-ACTIVATING PROTEINS; HEK293 CELLS; HUMANS; MALE; MICRORNAS; MUSCLE PROTEINS; MYOCARDIUM; NUCLEAR PROTEINS; RATS; RATS, SPRAGUE-DAWLEY; RNA INTERFERENCE; RNA, MESSENGER; TRANSCRIPTIONAL ACTIVATION; TRANSCRIPTOME; UP-REGULATION; VACUOLES;

RATTUS;

EID: 84864447013     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0040395     Document Type: Article

References (45)

1. Momparler RL, Karon M, Siegel SE, Avila F, ((1976)) Effect of Adriamycin on DNA, RNA, and Protein Synthesis in Cell-free Systems and Intact Cells. Cancer Research 36:: 2891--2895.
2. Jones RL, Swanton C, Ewer MS, ((2006)) Anthracycline cardiotoxicity. Expert Opinion on Drug Safety 5:: 791--809.
3. Bardi E, Bobok I, Olah V, Kappelmayer J, Kiss C, ((2007)) Anthracycline antibiotics induce acute renal tubular toxicity in children with cancer. Pathol Oncol Res 13:: 249--253.
4. Chen B, Peng X, Pentassuglia L, Lim C, Sawyer D, ((2007)) Molecular and cellular mechanisms of anthracycline cardiotoxicity. Cardiovascular Toxicology 7:: 114--121.
5. Storm G, van Hoesel QG, de GG, Kop W, Steerenberg PA, et al. ((1989)) A comparative study on the antitumor effect, cardiotoxicity and nephrotoxicity of doxorubicin given as a bolus, continuous infusion or entrapped in liposomes in the Lou/M Wsl rat. Cancer ChemotherPharmacol 24:: 341--348.
6. Hasinoff BB, Herman EH, ((2007)) Dexrazoxane: how it works in cardiac and tumor cells. Is it a prodrug or is it a drug? Cardiovasc Toxicol 7:: 140--144.
7. Herman EH, Ferrans VJ, ((1998)) Preclinical animal models of cardiac protection from anthracycline-induced cardiotoxicity. SeminOncol 25:: 15--21.
8. Gianni L, Herman EH, Lipshultz SE, Minotti G, Sarvazyan N, et al. ((2008)) Anthracycline Cardiotoxicity: From Bench to Bedside. Journal of Clinical Oncology 26:: 3777--3784.
9. Thompson K, Rosenzweig B, Zhang J, Knapton A, Honchel R,et al. (2009) Early alterations in heart gene expression profiles associated with doxorubicin cardiotoxicity in rats. Cancer Chemotherapy and Pharmacology.
10. Lee RC, Feinbaum RL, Ambros V, ((1993)) The C. elegans heterochronic gene lin-4 encodes small RNAs with antisense complementarity to lin-14. Cell 75:: 843--854.
11. He L, Hannon GJ, ((2004)) MicroRNAs: small RNAs with a big role in gene regulation. Nat Rev Genet 5:: 522--531.
12. Wu L, Belasco JG, ((2008)) Let Me Count the Ways: Mechanisms of Gene Regulation by miRNAs and siRNAs. Molecular Cell 29:: 1--7.
13. Filipowicz W, Bhattacharyya SN, Sonenberg N, ((2008)) Mechanisms of post-transcriptional regulation by microRNAs: are the answers in sight? Nat Rev Genet 9:: 102--114.
14. Guo H, Ingolia NT, Weissman JS, Bartel DP, ((2010)) Mammalian microRNAs predominantly act to decrease target mRNA levels. Nature 466:: 835--840.
15. Marson A, Levine SS, Cole MF, Frampton GM, Brambrink T, et al. ((2008)) Connecting microRNA genes to the core transcriptional regulatory circuitry of embryonic stem cells. Cell 134:: 521--533.
16. Croce CM, ((2009)) Causes and consequences of microRNA dysregulation in cancer. Nat Rev Genet 10:: 704--714.
17. Cullen BR, ((2006)) Viruses and microRNAs. Nature Genetics 38:: 525--530.
18. Umbach JL, Cullen BR, ((2009)) The role of RNAi and microRNAs in animal virus replication and antiviral immunity. Genes & Development 23:: 1151--1164.
19. Rodriguez A, Vigorito E, Clare S, Warren MV, Couttet P, et al. ((2007)) Requirement of bic/microRNA-155 for Normal Immune Function. Science 316:: 608--611.
20. van Rooij E, Sutherland LB, Liu N, Williams AH, McAnally J, et al. ((2006)) A signature pattern of stress-responsive microRNAs that can evoke cardiac hypertrophy and heart failure. Proc Natl Acad Sci U S A 103:: 18255--18260.
21. Thum T, Galuppo P, Wolf C, Fiedler J, Kneitz S, et al. ((2007)) MicroRNAs in the Human Heart: A Clue to Fetal Gene Reprogramming in Heart Failure. Circulation 116:: 258--267.
22. Latronico MVG, Condorelli G, ((2009)) MicroRNAs and cardiac pathology. Nat Rev Cardiol 6:: 418--429.
23. van Rooij E, Sutherland LB, Qi X, Richardson JA, Hill J, et al. ((2007)) Control of stress-dependent cardiac growth and gene expression by a microRNA. Science 316:: 575--579.
24. Callis TE, Pandya K, Seok HY, Tang RH, Tatsuguchi M, et al. ((2009)) MicroRNA-208a is a regulator of cardiac hypertrophy and conduction in mice. The Journal of Clinical Investigation 119:: 2772--2786.
25. Taylor EL, Gant TW, ((2008)) Emerging fundamental roles for non-coding RNA species in toxicology. Toxicology 246:: 34--39.
26. Kobayashi S, Volden P, Timm D, Mao K, Xu XM, et al. ((2010)) Transcription Factor GATA4 Inhibits Doxorubicin-induced Autophagy and Cardiomyocyte Death. Journal of Biological Chemistry 285:: 793--804.
27. Fimia GM, Stoykova A, Romagnoli A, Giunta L, Di Bartolomeo S, et al. ((2007)) Ambra1 regulates autophagy and development of the nervous system. Nature 447:: 1121--U1114.
28. de Bold AJ, Bruneau BG, Kuroski de Bold ML, ((1996)) Mechanical and neuroendocrine regulation of the endocrine heart. CardiovascRes 31:: 7--18.
29. Mikhailov AT, Torrado M, ((2008)) The enigmatic role of the ankyrin repeat domain 1 gene in heart development and disease. International Journal of Developmental Biology 52:: 811--821.
30. Dorn GW, Robbins J, Ball N, Walsh RA, ((1994)) Myosin heavy chain regulation and myocyte contractile depression after LV hypertrophy in aortic-banded mice. AmJPhysiol 267:: H400--H405.
31. Caulfield JB, Wolkowicz PE, ((1990)) Myocardial connective tissue alterations. Toxicol Pathol 18:: 488--496.
32. Suzuki T, Hayashi D, Yamazaki T, Mizuno T, Kanda Y, et al. ((1998)) Elevated B-type natriuretic peptide levels after anthracycline administration. Am Heart J 136:: 362--363.
33. Horie T, Ono K, Nishi H, Nagao K, Kinoshita M,et al. (2010) Acute Doxorubicin Cardiotoxicity Is Associated with miR-146a-induced Inhibition of the Neuregulin-ErbB Pathway. Cardiovascular Research:-.
34. Wang K, Li PF (2010) Foxo3a regulates apoptosis by negatively targeting miR-21. Journal of Biological Chemistry.
35. Xu C, Lu Y, Pan Z, Chu W, Luo X, et al. ((2007)) The muscle-specific microRNAs miR-1 and miR-133 produce opposing effects on apoptosis by targeting HSP60, HSP70 and caspase-9 in cardiomyocytes. J Cell Sci 120:: 3045--3052.
36. Cannell IG, Kong YW, Johnston SJ, Chen ML, Collins HM, et al. ((2010)) p38 MAPK/MK2-mediated induction of miR-34c following DNA damage prevents Myc-dependent DNA replication. Proceedings of the National Academy of Sciences 107:: 5375--5380.
37. Braun CJ, Zhang X, Savelyeva I, Wolff S, Moll UM, et al. ((2008)) p53-Responsive MicroRNAs 192 and 215 Are Capable of Inducing Cell Cycle Arrest. Cancer Research 68:: 10094--10104.
38. Georges SA, Biery MC, Kim Sy, Schelter JM, Guo J, et al. ((2008)) Coordinated Regulation of Cell Cycle Transcripts by p53-Inducible microRNAs, miR-192 and miR-215. Cancer Research 68:: 10105--10112.
39. He L, He X, Lowe SW, Hannon GJ, ((2007)) microRNAs join the p53 network- another piece in the tumour-suppression puzzle. Nat Rev Cancer 7:: 819--822.
40. van Rooij E, Quiat D, Johnson BA, Sutherland LB, Qi X, et al. ((2009)) A Family of microRNAs Encoded by Myosin Genes Governs Myosin Expression and Muscle Performance. Developmental Cell 17:: 662--673.
41. Minato N, Hattori M, ((2009)) Spa-1 (Sipa1) and Rap signaling in leukemia and cancer metastasis. Cancer Science 100:: 17--23.
42. Shimizu Y, Hamazaki Y, Hattori M, Doi K, Terada N, et al. ((2011)) SPA-1 controls the invasion and metastasis of human prostate cancer. Cancer Sci 102:: 828--836.
43. Crawford NP, Ziogas A, Peel DJ, Hess J, Anton-Culver H,et al. (2006) Germline polymorphisms in SIPA1 are associated with metastasis and other indicators of poor prognosis in breast cancer. Breast Cancer Res 8: R16-.
44. Jeyaraj SC, Unger NT, Chotani MA, ((2011)) Rap1 GTPases: an emerging role in the cardiovasculature. Life Sci 88:: 645--652.
45. Griffiths-Jones S, Saini HK, van Dongen S, Enright AJ, ((2008)) miRBase: tools for microRNA genomics. Nucleic Acids Research 36:: D154--D158.